Immune-mediated Pathogenic Mechanisms of Neuro-PASC in Veterans
Part of paid clinical trials in Portland, Oregon.
- Sponsor
- VA Office of Research and Development
- Study ID
- NCT06932237
- Status
- Recruiting
Conditions
- Long COVID
- Neuro-PASC
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Study Details
Mental health symptoms, including cognitive impairment ("brain fog"), following COVID-19 are of great concern to Veterans. This research seeks to advance understanding of the long-term effects of COVID-19 on neuropsychiatric and neurological functions, identifying clinically relevant biomarkers and directions for developing and testing therapeutic interventions. To accomplish these objectives the investigators are conducting a longitudinal study at two VA medical centers to: 1) assess and monitor cognitive function and psychiatric symptoms in Veterans post-COVID; 2) evaluate biomarkers of inflammation and signaling pathways associated with viral infection and neuropsychiatric function; and 3) integrate neuropsychiatric and neurological findings with biological data to identify biomarkers and clinical endpoints associated with disease progression or severity, as well as those for promoting brain repair and attenuating those symptoms.
Key Dates
- Start date
- Feb 20, 2025
- Status verified
- Mar 2026
- Primary completion
- Mar 31, 2028
- Completion
- Mar 31, 2028
Study Design
- Enrollment
- 200 participants (estimated)
Arms
- Arm: Neuro-PASCAll participants enrolled in the study will attend 4 study visits: 1) Screening, 2) Baseline, 3) 6-Month Follow-up, and 4) 12-Month Follow-up. At the Baseline, 6-Month, and 12-Month follow-up, participants will complete an online neuropsychological assessment, questionnaires, blood draw, and saliva collection
- Arm: Neuro-PASC-imagingA subset (60) of Portland VA only participants will be provided with the opportunity to complete an MRI visit at baseline and the 12-month follow-up.
Primary Outcome Measure
Fatigue Severity Scale (FSS) [ Time Frame: Baseline, 6-Month, 12-Month ]
Central Contacts
- Jennifer M Loftis, MA PhD(503) 220-8262
- Emily R Sano, MA(503) 220-8262
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| VA Portland Health Care System, Portland, OR | Portland | Oregon | 97207-2964 | Jennifer M Loftis, MA PhD (PRINCIPAL_INVESTIGATOR) |
| James H. Quillen VA Medical Center, Mountain Home, TN | Mountain Home | Tennessee | 37684 |
Find similar trials in Portland, OR
Related Studies
- Cardiovascular Autonomic and Immune Mechanism of Post COVID-19 Tachycardia SyndromeRecruiting · Vanderbilt University Medical Center · Nashville, Tennessee
- Long COVID Immune ProfilingRecruiting · Vanderbilt University Medical Center · Nashville, Tennessee
- Utilizing Novel Blood RNA Biomarkers as a Diagnostic Tool in the Identification of Long COVID-19Recruiting · MaxWell Clinic, PLC · Iowa City, Iowa
- Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVIDPHASE3 · Recruiting · Wes Ely · Tucson, Arizona